HRP20020305A8 - 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof - Google Patents

2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof

Info

Publication number
HRP20020305A8
HRP20020305A8 HR20020305A HRP20020305A HRP20020305A8 HR P20020305 A8 HRP20020305 A8 HR P20020305A8 HR 20020305 A HR20020305 A HR 20020305A HR P20020305 A HRP20020305 A HR P20020305A HR P20020305 A8 HRP20020305 A8 HR P20020305A8
Authority
HR
Croatia
Prior art keywords
necrosis factor
thia
intermediates
preparation
dibenzoazulenes
Prior art date
Application number
HR20020305A
Other languages
English (en)
Croatian (hr)
Inventor
Merep Mladen
Mesi Milan
Pe�i� Dijana
Ozimec Ivana
Original Assignee
GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. filed Critical GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o.
Priority to HR20020305A priority Critical patent/HRP20020305A8/xx
Priority to YU88304A priority patent/YU88304A/sh
Priority to US10/510,866 priority patent/US7435834B2/en
Priority to AT03745849T priority patent/ATE320433T1/de
Priority to CNA038094932A priority patent/CN1649875A/zh
Priority to PCT/HR2003/000016 priority patent/WO2003084962A1/en
Priority to IL16439603A priority patent/IL164396A0/xx
Priority to EP03745849A priority patent/EP1509530B1/de
Priority to NZ535620A priority patent/NZ535620A/xx
Priority to PL03372748A priority patent/PL372748A1/xx
Priority to MXPA04009943A priority patent/MXPA04009943A/es
Priority to SI200330275T priority patent/SI1509530T1/sl
Priority to DK03745849T priority patent/DK1509530T3/da
Priority to JP2003582159A priority patent/JP2005526828A/ja
Priority to ES03745849T priority patent/ES2260637T3/es
Priority to CA002481514A priority patent/CA2481514A1/en
Priority to BR0309094-9A priority patent/BR0309094A/pt
Priority to AU2003259963A priority patent/AU2003259963A1/en
Priority to PT03745849T priority patent/PT1509530E/pt
Priority to DE60304048T priority patent/DE60304048T2/de
Priority to RU2004132868/04A priority patent/RU2334749C2/ru
Priority to UA20041008547A priority patent/UA79277C2/uk
Publication of HRP20020305A2 publication Critical patent/HRP20020305A2/hr
Priority to IS7474A priority patent/IS7474A/is
Priority to ZA200408063A priority patent/ZA200408063B/en
Priority to US10/965,659 priority patent/US20050131056A1/en
Priority to NO20044506A priority patent/NO20044506L/no
Priority to CY20061100649T priority patent/CY1105036T1/el
Publication of HRP20020305A8 publication Critical patent/HRP20020305A8/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C07D333/80Seven-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
HR20020305A 2002-04-10 2002-04-10 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof HRP20020305A8 (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
HR20020305A HRP20020305A8 (en) 2002-04-10 2002-04-10 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
JP2003582159A JP2005526828A (ja) 2002-04-10 2003-04-09 腫瘍壊死因子産生の阻害剤としての2−チア−ジベンゾアズレン類及びその製造用中間体
RU2004132868/04A RU2334749C2 (ru) 2002-04-10 2003-04-09 2-тиадибензоазулены в качестве ингибиторов продуцирования фактора некроза опухоли и промежуточные продукты для их получения
AT03745849T ATE320433T1 (de) 2002-04-10 2003-04-09 2-thia-dibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung
CNA038094932A CN1649875A (zh) 2002-04-10 2003-04-09 作为肿瘤坏死因子产生抑制剂的2-硫杂-二苯并薁及用于其制备的中间体
PCT/HR2003/000016 WO2003084962A1 (en) 2002-04-10 2003-04-09 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
IL16439603A IL164396A0 (en) 2002-04-10 2003-04-09 2-Thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
EP03745849A EP1509530B1 (de) 2002-04-10 2003-04-09 2-thia-dibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung
NZ535620A NZ535620A (en) 2002-04-10 2003-04-09 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
PL03372748A PL372748A1 (en) 2002-04-10 2003-04-09 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
MXPA04009943A MXPA04009943A (es) 2002-04-10 2003-04-09 2-tiadibenzoazulenos como inhibidores de la produccion de factor de necrosis tumoral e intermediarios para su preparacion.
SI200330275T SI1509530T1 (sl) 2002-04-10 2003-04-09 2-tia-dibenzoazuleni kot inhibitorji proizvodnje tumorje nekrotizirajocega faktorja in intermediatiza njihovo pripravo
DK03745849T DK1509530T3 (da) 2002-04-10 2003-04-09 2-Thia-dibenzoazulener som inhibitorer af tumornekrosefaktorproduktion og mellemprodukter til fremstilling deraf
YU88304A YU88304A (sh) 2002-04-10 2003-04-09 2-tia-dibenzoazuleni kao inhibitori stvaranja faktora tumorske nekroze i međuproizvodi za njihovo pripremanje
ES03745849T ES2260637T3 (es) 2002-04-10 2003-04-09 2-tiadibenzoazuleno como inhibidores de la produccion del factor de necrosis tumoral e intermediarios para su preparacion.
DE60304048T DE60304048T2 (de) 2002-04-10 2003-04-09 2-thia-dibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung
BR0309094-9A BR0309094A (pt) 2002-04-10 2003-04-09 2-tia-dibenzoazulenos como inibidores da produção do fator de necrose de tumor e intermediários para a preparação dos mesmos
AU2003259963A AU2003259963A1 (en) 2002-04-10 2003-04-09 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
PT03745849T PT1509530E (pt) 2002-04-10 2003-04-09 2-tia-dibenzoazulenos como inibidores da producao do factor de necrose tumoral e intermediarios para a producao destes
CA002481514A CA2481514A1 (en) 2002-04-10 2003-04-09 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
US10/510,866 US7435834B2 (en) 2002-04-10 2003-04-09 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
UA20041008547A UA79277C2 (en) 2002-04-10 2003-09-04 2-thia-dibenzoazulenes as inhibitors of tumors necrosis factor production, process for the preparation and use thereof
IS7474A IS7474A (is) 2002-04-10 2004-09-27 1-Þía-bensónaftóasúlen sem hindrar fyrir æxlisdrepþáttar framleiðslu og milliefni til framleiðslu þeirra
ZA200408063A ZA200408063B (en) 2002-04-10 2004-10-06 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
US10/965,659 US20050131056A1 (en) 2002-04-10 2004-10-12 2- thia-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
NO20044506A NO20044506L (no) 2002-04-10 2004-10-21 2-tia-dibenzoazulener som inhibitorer for tumornekrosefaktorproduksjon og mellomprodukter for fremstilling derav
CY20061100649T CY1105036T1 (el) 2002-04-10 2006-05-18 2-θεια-διβενζοαζουλενια ως αναστολεις της παραγωγης του παραγοντα νεκρωσης ογκων και ενδιαμεσα για την παρασκευη αυτων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HR20020305A HRP20020305A8 (en) 2002-04-10 2002-04-10 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof

Publications (2)

Publication Number Publication Date
HRP20020305A2 HRP20020305A2 (en) 2003-10-31
HRP20020305A8 true HRP20020305A8 (en) 2009-03-31

Family

ID=28686903

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020305A HRP20020305A8 (en) 2002-04-10 2002-04-10 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof

Country Status (26)

Country Link
US (1) US7435834B2 (de)
EP (1) EP1509530B1 (de)
JP (1) JP2005526828A (de)
CN (1) CN1649875A (de)
AT (1) ATE320433T1 (de)
AU (1) AU2003259963A1 (de)
BR (1) BR0309094A (de)
CA (1) CA2481514A1 (de)
CY (1) CY1105036T1 (de)
DE (1) DE60304048T2 (de)
DK (1) DK1509530T3 (de)
ES (1) ES2260637T3 (de)
HR (1) HRP20020305A8 (de)
IL (1) IL164396A0 (de)
IS (1) IS7474A (de)
MX (1) MXPA04009943A (de)
NO (1) NO20044506L (de)
NZ (1) NZ535620A (de)
PL (1) PL372748A1 (de)
PT (1) PT1509530E (de)
RU (1) RU2334749C2 (de)
SI (1) SI1509530T1 (de)
UA (1) UA79277C2 (de)
WO (1) WO2003084962A1 (de)
YU (1) YU88304A (de)
ZA (1) ZA200408063B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020304B1 (en) * 2002-04-10 2008-04-30 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
HRP20020305A8 (en) 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020452A2 (en) * 2002-05-23 2004-02-29 Pliva D D 1,2-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
HRP20030885A2 (en) * 2003-11-03 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS
HRP20030956A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1,2-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANU
WO2007075772A2 (en) * 2005-12-20 2007-07-05 President And Fellows Of Harvard College Compounds, screens, and methods of treatment

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3711489A (en) * 1971-03-31 1973-01-16 Pfizer Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles
CA967573A (en) 1972-12-22 1975-05-13 Joseph G. Lombardino Tetracyclic anti-inflammatory agents
NL7605526A (nl) * 1976-05-24 1977-11-28 Akzo Nv Nieuwe tetracyclische derivaten.
US4198421A (en) * 1978-11-30 1980-04-15 E. I. Du Pont De Nemours And Company Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles
FR2504140A1 (fr) 1981-04-16 1982-10-22 Centre Nat Rech Scient Nouveaux derives tetracycliques de la dibenzazepine, leur procede de preparation et les compositions pharmaceutiques en renfermant
EP0125484A1 (de) 1983-04-12 1984-11-21 Ciba-Geigy Ag Polycyclische Carbonsäureverbindungen, Verfahren zu ihrer Herstellung und Präparate enthaltend solche Carbonsäureverbindungen, sowie deren Verwendung
IE62754B1 (en) 1988-08-26 1995-02-22 Akzo Nv Tetracyclic antidepressants
IT1227527B (it) 1988-12-05 1991-04-12 Ciatti Maurizio Spazzolino da denti a setole rotanti
US5552399A (en) 1994-11-02 1996-09-03 Janssen Pharmaceutica N.V. Substituted tetracyclic azepine derivatives
CA2203664A1 (en) 1994-11-02 1996-05-17 Francisco Javier Fernandez-Gadea Substituted tetracyclic oxazepine and thiazepine derivatives with 5-ht2 receptor affinity
PT892793E (pt) 1996-04-12 2003-08-29 Janssen Pharmaceutica Nv Derivados 2-cianoiminoimidazolo inibidores da pde iv
UA52778C2 (uk) * 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
HRP20000310A2 (en) * 2000-05-17 2002-02-28 Pliva Farmaceutska Ind Dioniko New dibenzoazulene compounds as tumor necrosis factor inhibitors
HRP20020305A8 (en) 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20030957A2 (en) 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1-THIA-3-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20040104A2 (en) 2004-01-30 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders

Also Published As

Publication number Publication date
HRP20020305A2 (en) 2003-10-31
DK1509530T3 (da) 2006-07-17
CY1105036T1 (el) 2010-03-03
BR0309094A (pt) 2005-02-09
IS7474A (is) 2004-09-27
EP1509530A1 (de) 2005-03-02
US7435834B2 (en) 2008-10-14
NO20044506L (no) 2004-11-09
ES2260637T3 (es) 2006-11-01
ATE320433T1 (de) 2006-04-15
ZA200408063B (en) 2006-07-26
JP2005526828A (ja) 2005-09-08
RU2334749C2 (ru) 2008-09-27
DE60304048D1 (de) 2006-05-11
DE60304048T2 (de) 2006-10-19
SI1509530T1 (sl) 2006-08-31
UA79277C2 (en) 2007-06-11
NZ535620A (en) 2006-03-31
CA2481514A1 (en) 2003-10-16
PT1509530E (pt) 2006-07-31
PL372748A1 (en) 2005-08-08
CN1649875A (zh) 2005-08-03
US20050182126A1 (en) 2005-08-18
IL164396A0 (en) 2005-12-18
EP1509530B1 (de) 2006-03-15
MXPA04009943A (es) 2005-09-30
RU2004132868A (ru) 2005-06-10
YU88304A (sh) 2006-08-17
WO2003084962A1 (en) 2003-10-16
AU2003259963A1 (en) 2003-10-20

Similar Documents

Publication Publication Date Title
GEP20084435B (en) Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
ATE437872T1 (de) Proteinkinaseinhibitoren
ATE469142T1 (de) Heterocyclische amid-derivate als cytokin- inhibitoren
HRP20020305A8 (en) 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
ATE399175T1 (de) Hemmstoffe der urokinase, ihre herstellung und verwendung
IL164395A0 (en) 1-Or-3-thia-benzonaphthoazulees as inhibitors of tumour necrosis factor production and intermediatesfor the preparation thereof
WO2003099823A3 (en) 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
RS100004A (en) 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
WO2003097649A3 (en) 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
YU88204A (sh) 1-oksa 3-aza-dibenzoazuleni kao inhibitori stvaranja faktora tumorske nekroze i međuproizvodi za njihovo pripremanje
ATE460410T1 (de) 2-arylcarbamoyl-indole als zytokinhemmer
BRPI0514907A (pt) derivados do pirrol [3,2 -c] piridina e processos para a sua preparação
RS100204A (en) 1,2-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PPPP Transfer of rights

Owner name: PLIVA-ISTRAZIVACKI INSTITUT D.O.O., HR

PNAN Change of the applicant name, address/residence

Owner name: GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O.,

ODRP Renewal fee for the maintenance of a patent

Payment date: 20080402

Year of fee payment: 7

AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
A8IS Corrected front page of an hr-a document
ODBI Application refused